Plus   Neg

Myriad Genetics Inc. Q2 adjusted earnings of $0.38 per share

Myriad Genetics Inc. (MYGN) released earnings for second quarter that declined from the same period last year.

The company's earnings totaled $2.6 million, or $0.03 per share. This compares with $30.9 million, or $0.43 per share, in last year's second quarter.

Excluding items, Myriad Genetics Inc. reported adjusted earnings of $29.2 million or $0.38 per share for the period.

The company's revenue for the quarter rose 15.4% to $216.8 million from $187.9 million last year.

Myriad Genetics Inc. earnings at a glance:

-Earnings (Q2): $29.2 Mln. vs. $25.9 Mln. last year.
-EPS (Q2): $0.38 vs. $0.36 last year.
-Revenue (Q2): $216.8 Mln vs. $187.9 Mln last year.

Next quarter EPS guidance: $0.42 - $0.44
Next quarter revenue guidance: $216 - $218 Mln
Full year EPS guidance: $1.70 - $1.75
Full year revenue guidance: $855 - $865 Mln

For comments and feedback contact: editorial@rttnews.com

Follow RTT